Evaluation of Rituximab Efficacy and Safety in Lymphoma
Clinical Trial
Offered by: ¾Ã¾Ã¾Ã¾Ã¾Ã¾Ã¾Ã¾«Æ· Children's
Locations: Delaware Valley and Pensacola in Florida
Trial Name
Intergroup Trial for Children or Adolescents With B-Cell Non-Hodgkin Lymphoma (NHL) or Mature B-Cell Leukemia (B-AL): Evaluation of Rituximab Efficacy and Safety in High Risk Patients
What is the trial about?
To see if using rituximab in combination with the DA-EPOCH chemotherapy will result in improved treatment outcome for children with PMLBL.
Who can participate?
6 months to < 18 yrs of age.
What is involved?
Length of study is 5 months. In addition to standard NHL care, other tests performed include immune system recovery blood tests and PET scans.
Is a Clinical Trial Right for Your Child?
Learn more about clinical trials and get answers to questions you might have.
